ID Source | ID |
---|---|
PubMed CID | 12079 |
CHEMBL ID | 57012 |
SCHEMBL ID | 57152 |
MeSH ID | M0286301 |
Synonym |
---|
EN300-18272 |
UPCMLD0ENAT5345030:001 |
m-cyanonitrobenzene |
3-cyanonitrobenzene |
619-24-9 |
benzonitrile, 3-nitro- |
3-nitrobenzonitrile |
nsc-5382 |
wln: wnr ccn |
nsc5382 |
m-nitrobenzonitrile |
benzonitrile, m-nitro- |
AC-907/25014352 |
inchi=1/c7h4n2o2/c8-5-6-2-1-3-7(4-6)9(10)11/h1-4 |
ai3-16310 |
ccris 2327 |
einecs 210-587-7 |
nsc 5382 |
3-nitrobenzonitrile, 98% |
STK260893 |
AC-10299 |
AKOS000304441 |
CHEMBL57012 |
3-nitro-benzonitrile |
N0170 |
A833486 |
3-nitrobenzenecarbonitrile |
3-cyano-1-nitrobenzene |
FT-0616243 |
PS-4576 |
SCHEMBL57152 |
3-nitrobenzonitril |
m-nitrocyanobenzene |
3-cyanonitrobenzene- |
DTXSID5060697 |
W-105077 |
mfcd00007194 |
12402-46-9 |
D73176 |
meta-cyanonitrobenzene |
benzonitrile, 3-nitro-, radical ion(1-) (9ci) |
CS-0059137 |
Q63399425 |
A935271 |
SY008007 |
Z57756579 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID23714 | Partition coefficient (logP) | 1988 | Journal of medicinal chemistry, Oct, Volume: 31, Issue:10 | A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. |
AID23978 | Capacity ratio (log k'w) | 1988 | Journal of medicinal chemistry, Oct, Volume: 31, Issue:10 | A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. |
AID203473 | Binding constant against bovine serum albumin | 1988 | Journal of medicinal chemistry, Oct, Volume: 31, Issue:10 | A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |